Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates
Open Access
- 27 September 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (9) , e0249254
Abstract
Due to the widespread of the COVID-19 pandemic, the SARS-CoV-2 genome is evolving in diverse human populations. Several studies already reported different strains and an increase in the mutation rate. Particularly, mutations in SARS-CoV-2 spike-glycoprotein are of great interest as it mediates infection in human and recently approved mRNA vaccines are designed to induce immune responses against it. We analyzed 1,036,030 SARS-CoV-2 genome assemblies and 30,806 NGS datasets from GISAID and European Nucleotide Archive (ENA) focusing on non-synonymous mutations in the spike protein. Only around 2.5% of the samples contained the wild-type spike protein with no variation from the reference. Among the spike protein mutants, we confirmed a low mutation rate exhibiting less than 10 non-synonymous mutations in 99.6% of the analyzed sequences, but the mean and median number of spike protein mutations per sample increased over time. 5,472 distinct variants were found in total. The majority of the observed variants were recurrent, but only 21 and 14 recurrent variants were found in at least 1% of the mutant genome assemblies and NGS samples, respectively. Further, we found high-confidence subclonal variants in about 2.6% of the NGS data sets with mutant spike protein, which might indicate co-infection with various SARS-CoV-2 strains and/or intra-host evolution. Lastly, some variants might have an effect on antibody binding or T-cell recognition. These findings demonstrate the continuous importance of monitoring SARS-CoV-2 sequences for an early detection of variants that require adaptations in preventive and therapeutic strategies.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS CoronavirusJournal of Virology, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Data, disease and diplomacy: GISAID's innovative contribution to global healthGlobal Challenges, 2017
- Structure, Function, and Evolution of Coronavirus Spike ProteinsAnnual Review of Virology, 2016
- Unified representation of genetic variantsBioinformatics, 2015
- Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicityJournal of Experimental Medicine, 2014
- A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEffFly, 2012
- The European Nucleotide ArchiveNucleic Acids Research, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Discovery of an RNA virus 3′→5′ exoribonuclease that is critically involved in coronavirus RNA synthesisProceedings of the National Academy of Sciences, 2006